Taiyen Biotech Co., Ltd. (1737) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Taiyen Biotech Co., Ltd. (1737:TWSE), powered by AI.

Current Price
$31.75
Sector
Consumer Defensive
What is the Taiyen Biotech Co., Ltd. stock price forecast?

Taiyen Biotech Co., Ltd. is currently trading at $31.75. View real-time AI analysis on Alpha Lenz.

What is Taiyen Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Taiyen Biotech Co., Ltd. on Alpha Lenz.

What is Taiyen Biotech Co., Ltd.'s P/E ratio?

View Taiyen Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

Taiyen Biotech Co., Ltd.

TWSE · 1737
NT$31.75+0.05(+0.16%)
Ask about Taiyen Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Taiyen Biotech Co., Ltd.'s ROE is 5.9%. Explore profitability and growth together.

Ask for details

Company Overview

Taiyen Biotech Co., Ltd. is a leading biotechnology company that engages in the research, development, and production of a wide array of biotechnological products. Initially recognized for its development of essential healthcare commodities, Taiyen Biotech has expanded its portfolio to include a diverse range of health, beauty, and wellness products. The company is particularly noted for its expertise in marine-based biotechnologies, leveraging natural resources to innovate in the realms of skincare, nutritional supplements, and pharmaceuticals. With a focus on sustainability and environmental responsibility, Taiyen Biotech plays a crucial role in several industries—most prominently in healthcare and consumer goods. The company’s strategic initiatives often involve partnerships and collaborations that enhance its footprint in the biotechnology sector. In the financial markets, Taiyen Biotech is regarded as a key player within the biotechnology industry, offering insights into the intersection of natural resources and advanced scientific research, and contributing significantly to advancements in consumer health and wellness products. Headquartered in Taiwan, Taiyen Biotech continues to influence global biotech trends with its innovative approach to product development.

SectorConsumer Defensive
IndustryHousehold & Personal Products
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$3.31BRevenue
0.00Shares Out
0Employees

Margins

40.60%Gross
22.18%EBITDA
14.10%Operating
14.93%Pre-Tax
11.90%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-2.91%Rev 3Yr
1.11%Rev 5Yr
1.58%Op Inc 3Yr
0.14%Op Inc 5Yr
-2.71%Net Inc 3Yr
1.00%Net Inc 5Yr

Returns

4.73%ROA
5.93%ROE
5.98%ROIC

Financial Health

NT$1.35BCash & Cash Equivalents
NT$99.42MNet Debt
21.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Taiyen Biotech Co., Ltd. (ticker: 1737) is a company listed on TWSE in the Consumer Defensive sector (Household & Personal Products).

The current price is 31.75 with a P/E ratio of -x and P/B of -x.

ROE is 5.93% and operating margin is 14.10%. Annual revenue is $3.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Taiyen Biotech Co., Ltd. (1737) Stock Forecast 2026 $31.75 — Price, Financials & Analyst Targets | Alpha Lenz